{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:13:17Z","timestamp":1761581597717},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Kansas Medical Center Institutional Start-up Fund"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","respiratoryinvestigation.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.resinv.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T21:45:54Z","timestamp":1502919954000},"page":"308-313","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Who treats lung cancer? Results from a global survey"],"prefix":"10.1016","volume":"55","author":[{"given":"Takefumi","family":"Komiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine B.","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhakar","family":"Chalise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2017.07.002_bib1","unstructured":"World Health Organization: Cancer, key facts. [homepage on the Internet]. Available from: \u3008http:\/\/www.who.int\/mediacentre\/factsheets\/fs297\/en\/\u3009. [Accessed 10 November 2016]."},{"key":"10.1016\/j.resinv.2017.07.002_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jjco\/hyt038","article-title":"An updated report of the trends in cancer incidence and mortality in Japan","volume":"43","author":"Katanoda","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.resinv.2017.07.002_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"National Lung Screening Trial Research Team","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2017.07.002_bib4","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.2010.33.4235","article-title":"Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin\/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS)","volume":"29","author":"Fukuoka","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2017.07.002_bib5","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","article-title":"First-line crizotinib versus chemotherapy in ALK-positive lung cancer","volume":"371","author":"Solomon","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2017.07.002_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus Docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2017.07.002_bib7","unstructured":"Cancer Facts and Figures 2016. American Cancer Society. \u3008http:\/\/www.cancer.org\/acs\/groups\/content\/@research\/documents\/document\/acspc-047079.pdf\u3009. [Accessed 6 January 2017]."},{"key":"10.1016\/j.resinv.2017.07.002_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/jjco\/hyu059","article-title":"Current status of medical oncology in Japan--reality gleaned from a questionnaire sent to designated cancer care hospitals","volume":"44","author":"Takiguchi","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.resinv.2017.07.002_bib9","doi-asserted-by":"crossref","unstructured":"The state of cancer care in America 2016. American Society of Clinical Oncology; 2016. [homepage on the Internet]. Available from: \u3008http:\/\/www.asco.org\/research-progress\/reports-studies\/cancer-care-america-2016#\/appendixes\u3009. [Accessed 12 November 2016].","DOI":"10.1200\/JOP.2015.010462"},{"key":"10.1016\/j.resinv.2017.07.002_bib10","unstructured":"Japanese Society of Medical Oncology: Greetings from the president. [homepage on the Internet]. Available from: \u3008http:\/\/www.jsmo.or.jp\/about\/aisatsu.html\u3009. [Accessed 12 November 2016]."},{"key":"10.1016\/j.resinv.2017.07.002_bib11","article-title":"Status of oncologic specialties: global survey of physicians treating cancer","author":"Komiya","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.resinv.2017.07.002_bib12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ijcard.2015.09.017","article-title":"Structural heart interventions training in Europe","volume":"202","author":"Marmagkiolis","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.resinv.2017.07.002_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/JGO.2015.000158","article-title":"Global Practice and Efficiency of Multidisciplinary Tumor Boards: results of an American Society of Clinical Oncology International Survey","volume":"1","author":"El Saghir","year":"2015","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.resinv.2017.07.002_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2302\/kjm.17.1","article-title":"Flexible bronchofiberscope","volume":"17","author":"Ikeda","year":"1968","journal-title":"Keio J Med"},{"key":"10.1016\/j.resinv.2017.07.002_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-5002(01)00284-7","article-title":"Correlation between endobronchial ultrasonography (EBUS) images and histologic findings in normal and tumor-invaded bronchial wall","volume":"35","author":"Baba","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2017.07.002_bib16","unstructured":"National Hospital Organization Kinki Chuo Chest Medical Center. [homepage on the Internet]. Available from: \u3008http:\/\/www.hosp.go.jp\/~kch\/index.html\u3009. [Accessed 12 November 2016]."},{"key":"10.1016\/j.resinv.2017.07.002_bib17","unstructured":"Osaka Prefectural Medical Center for Respiratory and Allergic Diseases. [homepage on the Internet]. Available from: \u3008http:\/\/www.ra.opho.jp\/\u3009. [Accessed 12 November 2016]."},{"key":"10.1016\/j.resinv.2017.07.002_bib18","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1200\/JCO.2011.35.5214","article-title":"Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study","volume":"29","author":"Groen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2017.07.002_bib19","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2008.19.1650","article-title":"Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer","volume":"27","author":"Smit","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2017.07.002_bib20","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1200\/JCO.1992.10.7.1131","article-title":"Effects of recombinant human interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose-finding study","volume":"10","author":"Postmus","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2017.07.002_bib21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/01421590701724741","article-title":"Medical education in the Netherlands","volume":"29","author":"Cate","year":"2007","journal-title":"Med Teach"},{"key":"10.1016\/j.resinv.2017.07.002_bib22","unstructured":"European Society for Medical Oncology Medical Oncology Status in Europe Survey (MOSES), Phase III; 2008. \u3008http:\/\/www.esmo.org\/content\/download\/8358\/170037\/file\/2008-ESMOMOSES-PhaseIII.pdf\u3009. [Accessed 22 June 2016]."},{"key":"10.1016\/j.resinv.2017.07.002_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0300-2977(00)00099-1","article-title":"Consensus conference on palliative treatment of stage IV non-small cell lung cancer. Consensus meeting of the Netherlands Society for Medical Oncology and the Taskforce on Lung Cancer of the Dutch Society of Physicians for Lung Diseases and Tuberculosis","volume":"58","author":"Tjan-Heijnen","year":"2001","journal-title":"Neth J Med"},{"key":"10.1016\/j.resinv.2017.07.002_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s13187-016-1043-0","article-title":"Evaluation of association between gynecologic oncology fellowship length and a career in academic medicine","author":"Kesterson","year":"2016","journal-title":"J Cancer Educ"},{"key":"10.1016\/j.resinv.2017.07.002_bib25","unstructured":"Gynecologic fellowship programs. American Board of Obstetrics and Gynecology. \u3008https:\/\/www.abog.org\/new\/program.aspx?Type=4\u3009. [Accessed 7 January 2017]."}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534517300813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534517300813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T13:31:27Z","timestamp":1570023087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534517300813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2212534517300813"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2017.07.002","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Who treats lung cancer? Results from a global survey","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}